Pharma news
Pharma
Licensing of COVID-19 treatments has shifted to include other medicines and treatment areas | World’s largest pharma companies still “consistently overlook the poorest countries” | Report offers strategy to improve access. 16 November 2022
Pharma
Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system. 15 November 2022
Americas
Jazz accused a rival of infringement | Avadel filed a counterclaim seeking to delist the patent from the Orange Book. 15 November 2022
Pharma
Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices. 10 November 2022
Americas
The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition. 7 November 2022
Pharma
Cardiovascular ‘innovator’ snapped up as company strengthens medtech offering | Massachusetts-based Abiomed will become part of purchaser’s medtech division 2 November 2022
Pharma
The temporary injunction prevents a Pfizer unit from launching a generic| The dispute centres on a branded coronary artery test 1 November 2022
Pharma
The deal sees Sumitomo acquiring ownership of cancer and uterine fibroid treatments | Myovant initially rejected low offer that “undervalued” the company. 25 October 2022
Pharma
Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice. 20 October 2022
Pharma
Gilead will have an exclusive licence and will pay MacroGenics $60 million upfront | Deal includes tiered, double-digit royalties on worldwide net sales. 18 October 2022